Ultragenyx Pharmaceutical | RARE - Ingresos Por Ventas





Ventas Cambio Fecha
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Insmed USD 425.49M 119.53M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Kyowa Hakko Kirin JPY 145.16B 26.69B 2026-06
MacroGenics USD 20.8M 20.43M 2026-03
Moderna USD 100M 289M 2026-06
Neurocrine Biosciences USD 959M 148M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06